Tevogen Bio
TVGN6.56010.44% ( +0.620 )
Tevogen Bio (TVGN)
Tevogen Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf, precision T cell therapies for the treatment of infectious diseases, can...
- Open
- 6.120
- High
- 6.670
- Low
- 6.120
- Prev. Close
- 5.940
- Volume
- 8.20K
- Turnover
- 52.60K
- Avg Price
- 6.416
- Bid/Ask Ratio
- --
- Amplitude
- 9.26%
- 52wk High
- 69.995
- Volume Ratio
- 4.63
- Turnover Ratio
- 0.72%
Tevogen Bio Analyst Rating
View MoreForecast & Rating
Mar 4, 2026Price forecast
$100.001399.25%
Forecast & RatingHold
1analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · 1 hour ago
Tevogen amends bylaws to reflect corporate name change to Tevogen Inc
- PUBT · 1 day ago, 07:10 AM
Tevogen Bio Holdings rebrands as Tevogen Inc
- rttnews · 2 days ago, 10:34 PM
Top Biotech Gainers: GOSS To File Seralutinib NDA In Sep, OMER Gains On AZN's Loss, FBRX Acquired
- PUBT · Jul 23 at 04:30 PM
Tevogen Bio announces annual shareholder meeting
- StockTitan · Jul 13 at 01:15 PM
Tevogen Bio Announces 2026 Annual Meeting of Stockholders | TVGN Stock News
- StockTitan · Jun 9 at 06:30 AM
Tevogen Announces Formation of a Healthcare Services Initiative | TVGN Stock News
